These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 20380229)
1. [Discharge letter with therapeutic recommendations: you have to sort out!]. Stiefelhagen P MMW Fortschr Med; 2010 Mar; 152(10):31-2. PubMed ID: 20380229 [No Abstract] [Full Text] [Related]
2. [Insulin sparing and metabolic control with metformin-insulin combination]. Isnard F Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986 [No Abstract] [Full Text] [Related]
3. [Drug treatment of insulin resistance]. Tenoutasse S Rev Med Brux; 2009; 30(2):126-8. PubMed ID: 19517913 [No Abstract] [Full Text] [Related]
4. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin. Chazova I; Almazov VA; Shlyakhto E Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753 [TBL] [Abstract][Full Text] [Related]
5. [Assessment of efficacy of combined therapy with antihypertensive agents and biguanides in patients with metabolic syndrome]. Makolkin VI; Podzolkov VI; Napalkov DA Kardiologiia; 2004; 44(10):39-42. PubMed ID: 15477788 [TBL] [Abstract][Full Text] [Related]
6. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis. Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770 [TBL] [Abstract][Full Text] [Related]
7. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines. Ansari G; Mojtahedzadeh M; Kajbaf F; Najafi A; Khajavi MR; Khalili H; Rouini MR; Ahmadi H; Abdollahi M Adv Ther; 2008 Jul; 25(7):681-702. PubMed ID: 18636232 [TBL] [Abstract][Full Text] [Related]
8. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome. Herrmann BL; Saller B; Stratmann M; Berg C; Mann K; Janssen OE Horm Metab Res; 2005 Jan; 37(1):49-52. PubMed ID: 15702440 [TBL] [Abstract][Full Text] [Related]
9. Normalization of metabolic syndrome using fenofibrate, metformin or their combination. Nieuwdorp M; Stroes ES; Kastelein JJ; Diabetes Obes Metab; 2007 Nov; 9(6):869-78. PubMed ID: 17924869 [TBL] [Abstract][Full Text] [Related]
17. Case 2. Recurrence of myocardial infarction. Tanser P; Archer S; Feldman R Can J Cardiol; 2000 Aug; 16 Suppl E():24E-26E. PubMed ID: 10906622 [TBL] [Abstract][Full Text] [Related]
18. Early pharmacological intervention in newly diagnosed metabolic syndrome and type 2 diabetes. Naruszewicz M Przegl Lek; 2006; 63 Suppl 4():7-8. PubMed ID: 16967707 [No Abstract] [Full Text] [Related]
19. [Metformin should not be used by patients with reduced renal function]. Gudmundsdottir H; Brørs O; Os I Tidsskr Nor Laegeforen; 2008 Apr; 128(8):936-7. PubMed ID: 18431417 [No Abstract] [Full Text] [Related]
20. A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients. Pala L; Mannucci E; Dicembrini I; Rotella CM Diabetes Res Clin Pract; 2007 Oct; 78(1):132-5. PubMed ID: 17445933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]